CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
04. Dezember 2024 17:00 ET
|
iCAD, Inc.
NASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated...
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
26. November 2024 13:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
13. November 2024 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance
12. November 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that...
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
06. November 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
05. November 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 05, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
03. Oktober 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today...
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
11. September 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
13. August 2024 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
06. August 2024 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...